The Iditarod Trail Committee released a statement Tuesday clearing four-time champion Dallas Seavey of any wrongdoing in a doping incident that happened more than a year-and-a-half ago.
The race’s board of directors says it does not believe Seavey “had any involvement with, or knowledge of, the events that led to the positive (drug) test in his team.” They also apologized for negative publicity the incident caused him.
In 2017, after arriving in Nome, several of Seavey‘s sled dogs tested positive for the banned pain medication Tramadol. Seavey has maintained that he never gave the drug to any of his dogs, and he has vocally criticized how the investigation was handled by ITC and its past board members.
In this latest statement, Seavey strikes a conciliatory note, saying he was grateful for the resolution under the new board and the steps that race officials have taken to increase safety along the trail. But Seavey stops short of saying whether or not he’ll be signing up to race this upcoming Iditarod in March.
Reached by phone Tuesday afternoon, Seavey said he’s considering his options, but the decision does not have anything to do with the race’s management. At this point, he has not signed up for any races.
The 2019 Iditarod starts March 2 in Anchorage.
- The featured ingredient in these new gluten-free “protein noodles” might surprise you: It’s pollock, the unassuming whitefish caught by the millions in the Bering Sea off Alaska’s coast.
- It’s going to be a busy year for Donlin Gold. The company is gearing up for another round of geotechnical drilling — its first in two years.
- The deadline is May 3 for the public to submit suggestions for the most cost-effective way to dispose of the Lumberman. The tugboat is anchored on state tidelands across from Egan Drive.
- American Rivers, a national advocacy group opposed to mining and energy development in wilderness areas, says the two Southeast Alaska rivers are "at a crossroads."